These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8981529)

  • 1. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis.
    Lu Y; Hylander B; Brauner A
    Perit Dial Int; 1996; 16(6):607-12. PubMed ID: 8981529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Kozioł-Montewka M; Ksiazek A; Janicka L; Baranowicz I
    Inflamm Res; 1997 Apr; 46(4):132-6. PubMed ID: 9137991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
    Lin CY; Lin CC; Huang TP
    Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis.
    Mlambo NC; Hylander B; Brauner A
    Inflammation; 1999 Apr; 23(2):131-9. PubMed ID: 10213269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
    Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG
    Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH; Lin CY
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
    Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis.
    Dasgupta MK; Larabie M; Halloran PF
    Kidney Int; 1994 Aug; 46(2):475-81. PubMed ID: 7967361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte stimulating factor in patients on peritoneal dialysis and LPS stimulated peripheral blood mononuclear cells.
    Brauner A; Hylander B; Lu Y
    Inflammation; 1998 Aug; 22(4):393-401. PubMed ID: 9675610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Nakahama H; Tanaka Y; Shirai D; Miyazaki M; Imai N; Yokokawa T; Okada M; Kubori S
    Nephron; 1992; 61(2):132-4. PubMed ID: 1630534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.
    Zemel D; Imholz AL; de Waart DR; Dinkla C; Struijk DG; Krediet RT
    Kidney Int; 1994 Nov; 46(5):1422-30. PubMed ID: 7853803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
    Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT
    Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.